Perimeter Medical Imaging AI Recognized as a TSX Venture 50 Company
24 Febrero 2022 - 7:30AM
Business Wire
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF)
(FSE:4PC) (“Perimeter” or the “Company”), a medical technology
company driven to transform cancer surgery with
ultra-high-resolution, real-time, advanced imaging tools to address
high unmet medical needs, is pleased to announce today that it has
been named as one of the 2022 Venture 50 Companies by the TSX
Venture Exchange. Perimeter was the sixth-ranked company in the
clean tech & life science sector with a market cap increase of
approximately 79% and a share price increase of 55% in 2021.
Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “We
are honored to be named as one of the Venture 50 Companies and see
this recognition as further validation of the significant progress
made in both the commercial and clinical development areas of our
business in 2021. Our TSX Venture listing has provided Perimeter
with increased awareness from both the capital and commercial
markets, access to capital, and additional support to drive our
business forward.”
Each year, 10 companies are selected from five key sectors,
based on their performance across three equally weighted criteria –
market cap growth, share price appreciation, and trading and
liquidity. The TSX Venture 50 program shines a light on their
successes and contributions to driving growth in the Canadian
economy, creating jobs, and building shareholder value.
A video showcasing Perimeter’s ranking on the 2022 Venture 50
Companies has been posted online and is also available on the
Investor section of Perimeter’s website.
Representatives from the 2022 TSX Venture 50 companies will join
Loui Anastasopoulos, President, Capital Formation and Enterprise
Marketing Officer, TMX Group., to virtually open the market at 9:30
a.m. ET today to celebrate this achievement. For more information
on the TSX Venture 50, visit: Tsx.com/Venture50.
About Perimeter Medical Imaging AI, Inc. Based in
Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI
(TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company
driven to transform cancer surgery with ultra-high-resolution,
real-time, advanced imaging tools to address areas of high unmet
medical need. Available across the U.S., our FDA-cleared Perimeter
S-Series OCT system provides real-time, cross-sectional
visualization of excised tissues at the cellular level. The
breakthrough-device-designated investigational Perimeter B-Series
OCT with ImgAssist AI represents our next-generation, artificial
intelligence technology that is currently under clinical
development. The company’s ticker symbol “PINK” is a reference to
the pink ribbons used during Breast Cancer Awareness Month.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Forward-Looking Statements
This news release contains statements that constitute
“forward-looking information” within the meaning of applicable
Canadian securities legislation. In this news release, words such
as “may”, “would”, “could”, “will”, “likely”, “believe”, “expect”,
“anticipate”, “intend”, “plan”, “estimate” and similar words and
the negative form thereof are used to identify forward-looking
statements. Forward-looking information may relate to management’s
future outlook and anticipated events or results and may include
statements or information regarding the future financial position,
business strategy and strategic goals, competitive conditions,
research and development activities, projected costs and capital
expenditures, research and clinical testing outcomes, taxes and
plans and objectives of, or involving, Perimeter. Without
limitation, information regarding Perimeter’s ongoing clinical
trials and product development are forward-looking information.
Forward-looking statements should not be read as guarantees of
future performance or results, and will not necessarily be accurate
indications of whether, or the times at or by which, any particular
result will be achieved. No assurance can be given that any events
anticipated by the forward-looking information will transpire or
occur. Forward-looking information is based on information
available at the time and/or management’s good-faith belief with
respect to future events and are subject to known or unknown risks,
uncertainties, assumptions, and other unpredictable factors, many
of which are beyond Perimeter’s control. Such forward-looking
statements reflect Perimeter’s current view with respect to future
events, but are inherently subject to significant medical,
scientific, business, economic, competitive, political, and social
uncertainties and contingencies. In making forward-looking
statements, Perimeter may make various material assumptions,
including but not limited to (i) the accuracy of Perimeter’s
financial projections; (ii) obtaining positive results from trials;
(iii) obtaining necessary regulatory approvals; and (iv) general
business, market, and economic conditions. Further risks,
uncertainties and assumptions include, but are not limited to,
those applicable to Perimeter and described in Perimeter’s
Management Discussion and Analysis for the year ended December 31,
2020, which is available on Perimeter’s SEDAR profile at
www.sedar.com, and could cause actual events or results to differ
materially from those projected in any forward-looking statements.
Perimeter does not intend, nor does Perimeter undertake any
obligation, to update or revise any forward-looking information
contained in this news release to reflect subsequent information,
events, or circumstances or otherwise, except if required by
applicable laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220224005416/en/
Shushu Feng Perimeter Medical Imaging AI, Inc. Direct:
647-339-7465 (PINK) Toll-free: 888-988-7465 (PINK)
investors@perimetermed.com
Simplify Exchang (NYSE:PINK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Simplify Exchang (NYSE:PINK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024